Compare AGIG & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGIG | PAVM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | 2 | 41 |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 52.1M |
| IPO Year | N/A | N/A |
| Metric | AGIG | PAVM |
|---|---|---|
| Price | $1.16 | $6.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 215.5K | 14.0K |
| Earning Date | 05-19-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $0.21 |
| 52 Week High | $5.31 | $28.44 |
| Indicator | AGIG | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 29.14 |
| Support Level | $1.01 | $6.11 |
| Resistance Level | $1.68 | $10.98 |
| Average True Range (ATR) | 0.08 | 0.43 |
| MACD | 0.03 | -0.18 |
| Stochastic Oscillator | 47.83 | 6.67 |
Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.